Cytiva

Pharma

Regulatory, policy uncertainties harm biopharma planning: Cytiva

Uncertain policy and inconsistent regulatory approaches are hamstringing biopharma's ability to plan for the long term, Cytiva warned in a new report.

Fraiser Kansteiner Oct 8, 2025 3:11pm

layoffs cuts workforce reduction chairs boxes fired

Cytiva to reduce head count at Massachusetts facility by 85

Mar 4, 2025 9:45am

Biopharmas struggle to meet sustainability challenges: survey

Aug 21, 2024 1:15pm

Kite will evaluate Cellares' cell therapy manufacturing platform

Jun 27, 2024 8:00am

Cytiva rolls out new CAR-T manufacturing platform

May 30, 2024 9:19am

Cytiva expansion tear continues with CEVEC Pharma acquisition

Oct 6, 2022 9:10am